control group:Azacytidine

2 trials

Sponsors

Bone Marrow Transplantation Center of the First Affiliated Hospital, College of Medicine, Zhejiang University, West China Hospital Shangjinnanfu Hospital

Conditions

Acute Myelocytic Leukemia / Myelodysplastic Syndrome EB1/2Acute myeloid leukemia

Early Phase 1

Azacytidine combined with immuno-detection point inhibitor (Cindigomab) in the treatment of elderly acute myeloid leukemia with increased leukemia residual disease or recurrent after microtransplantation: a single-center prospective non-randomized controlled clinical trial

Active, not recruitingChiCTR1900025147

Bone Marrow Transplantation Center of the First Affiliated Hospital, College of Medicine, Zhejiang UniversityAcute myeloid leukemia

Start: 2019-09-01Updated: 2019-08-27

Phase 4

Clinical Study on the Treatment of Elderly Acute Myelocytic Leukemia and Myelodysplastic Syndrome with Azacytidine Combined PD-1 Monoclonal Antibody

RecruitingChiCTR2000034927

West China Hospital Shangjinnanfu HospitalAcute Myelocytic Leukemia / Myelodysplastic Syndrome EB1/2

Start: 2020-08-01Updated: 2020-11-24